Patient-Centric Approaches to Improve Timely Diagnosis and Personalized Management of Primary Immunodeficiency (PID)

Case-based Education

Although clinical presentation is variable, most primary immunodeficiencies (PI/PID), also referred to as inborn errors of immunity, are associated with increased susceptibility to infections and may remain undiagnosed for many years -- usually detected only after a patient has experienced recurrent or severe infections, which may cause permanent organ damage.

Infections related to PIDs because of delayed diagnosis and treatment can become chronic and produce long-lasting health concerns or, in severe cases, may be fatal, making a timely diagnosis and initiation of treatment vital. And once diagnosed, specialists must work collaboratively with patients to personalize therapy selection from the wide and growing array of IVIG and SCIG formulations available, each with specific clinical advantages and disadvantages that must be considered, along with patient preference, satisfaction, and quality of life.

To prevent the occurrence of unnecessary comorbidities and infections, enhance patient quality of life, and reduce the cost of care burden, expert faculty will review real-world cases and discuss opportunities to facilitate earlier diagnosis and ensure optimal implementation of individualized treatment in patients with PID.

Faculty: Richard L. Wasserman, MD, PhD; Kenneth Paris, MD; Niraj Patel, MD, MS

Release Date: April 15, 2025

Expiration Date: April 15, 2026